Prelude Capital Management’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-16,800
| Closed | -$492K | – | 1942 |
|
|
2017
Q3 | $492K | Buy |
16,800
+14,700
| +700% | +$412K | 0.04% | 383 |
|
|
2017
Q2 | $55K | Sell |
2,100
-8,232
| -80% | -$202K | 0.01% | 976 |
|
|
2017
Q1 | $242K | Buy |
10,332
+6,280
| +155% | +$155K | 0.02% | 502 |
|
|
2016
Q4 | $102K | Sell |
4,052
-6,144
| -60% | -$155K | 0.01% | 825 |
|
|
2016
Q3 | $286K | Buy |
+10,196
| New | +$261K | 0.03% | 450 |
|
|
2016
Q2 | – | Sell |
-7,000
| Closed | -$155K | – | 1854 |
|
|
2016
Q1 | $155K | Buy |
7,000
+1,300
| +23% | +$34.6K | 0.02% | 632 |
|
|
2015
Q4 | $200K | Buy |
+5,700
| New | +$179K | 0.03% | 572 |
|
|
2015
Q2 | – | Sell |
-638
| Closed | -$18K | – | 2255 |
|
|
2015
Q1 | $18K | Sell |
638
-480
| -43% | -$11.9K | ﹤0.01% | 1766 |
|
|
2014
Q4 | $23K | Buy |
+1,118
| New | +$26.5K | ﹤0.01% | 1704 |
|
|
2014
Q3 | – | Sell |
-4,600
| Closed | -$132K | – | 2302 |
|
|
2014
Q2 | $132K | Buy |
4,600
+2,300
| +100% | +$64K | 0.02% | 967 |
|
|
2014
Q1 | $64K | Sell |
2,300
-1,820
| -44% | -$44.7K | 0.01% | 1200 |
|
|
2013
Q4 | $89K | Buy |
+4,120
| New | +$74.9K | 0.01% | 901 |
|
Prelude Capital Management's PMC Position: Q4 2017 in Review
Prelude Capital Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 16,800 shares — an estimated $492K sold.
Prelude Capital Management first reported a position in PMC in Q4 2013 and held it in 12 quarters. The position peaked at $492K in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Prelude Capital Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Prelude Capital Management sold 16,800 PharMerica Corporation shares in Q4 2017, an estimated $492K.
- Prelude Capital Management first reported a position in PharMerica Corporation in Q4 2013 and held it in 12 quarters.
- Prelude Capital Management's PharMerica Corporation position peaked at $492K in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.